Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166,422 | 175,311 | 254,712 | 267,818 | 309,498 |
| Marketable Securities | 342,318 | 285,168 | 261,217 | 243,200 | 215,522 |
| Receivables | 42,646 | 44,624 | 31,127 | 29,818 | 6,074 |
| Inventories | N/A | N/A | 1,024 | 242 | 128 |
| Other current assets | 16,291 | 8,613 | 6,839 | 7,407 | 5,529 |
| TOTAL | $567,677 | $513,716 | $554,919 | $548,485 | $536,751 |
| Non-Current Assets | |||||
| PPE Net | 18,775 | 11,825 | 10,811 | 9,140 | 6,954 |
| Investments And Advances | 249,388 | 276,319 | 247,361 | 210,258 | 205,768 |
| Other Non-Current Assets | 5,477 | 4,500 | 4,500 | 4,613 | 4,613 |
| TOTAL | $273,640 | $292,644 | $262,672 | $224,011 | $217,335 |
| Total Assets | $841,317 | $806,360 | $817,591 | $772,496 | $754,086 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 61,031 | 45,650 | 53,520 | 37,289 | 26,809 |
| Other current liabilities | 731 | 85 | 906 | N/A | N/A |
| TOTAL | $61,762 | $46,466 | $54,426 | $38,141 | $27,721 |
| Non-Current Liabilities | |||||
| Long Term Debt | 378,885 | 374,209 | 369,618 | 365,110 | 360,681 |
| Deferred Revenues | N/A | 731 | N/A | 731 | 731 |
| Other Non-Current Liabilities | 5,326 | 3,107 | 3,135 | 3,276 | 1,806 |
| TOTAL | $402,119 | $395,407 | $391,027 | $386,843 | $381,127 |
| Total Liabilities | $463,881 | $441,873 | $445,453 | $424,984 | $408,848 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 90,469 | 89,898 | 89,274 | 88,493 | 88,222 |
| Common Shares | 90 | 90 | 89 | 88 | 88 |
| Retained earnings | -1,246,597 | -1,240,684 | -1,198,866 | -1,205,760 | -1,194,635 |
| Other shareholders' equity | -2,809 | -3,697 | -1,850 | -534 | -713 |
| TOTAL | $377,436 | $364,487 | $372,138 | $347,512 | $345,238 |
| Total Liabilities And Equity | $841,317 | $806,360 | $817,591 | $772,496 | $754,086 |